Solvonis Therapeutics plcNew data supports lead alcohol use disorder programme ahead of planned Phase 2b trial.
Solvonis Therapeutics says new data supports its lead alcohol use disorder programme ahead of a planned Phase 2b trial, with CEO Anthony Tennyson noting the results could streamline development and open access to a market of around 15 million US adults. Tertiary Minerals has started its biggest-ever drilling programme in Zambia, aiming to define a maiden resource while testing for extensions and a potentially deeper sulphide system. CelLBxHealth is reshaping its strategy around cancer diagnostics and new pharma partnerships, with collaborations with AstraZeneca and AdventHealth potentially expanding clinical use of its Parsortix platform. Coinsilium Group says Bitcoin remains just one part of its growth story, as it also targets opportunities in AI, prediction markets and blockchain infrastructure. Eco Buildings Group has begun building its AI-enabled manufacturing platform in Albania, designed to boost efficiency and support global expansion. Frontier IP Group says a €211 million funding boost for portfolio company 2D Photonics marks a major milestone, with CEO Neil Crabb also highlighting progress across its AI, energy and healthcare investments.
Solvonis Therapeutics plcNew data supports lead alcohol use disorder programme ahead of planned Phase 2b trial.
CelLBxHealth plcNew pharma partnerships with AstraZeneca and AdventHealth could expand clinical use of its Parsortix platform.
AstraZeneca PLC
Tertiary Minerals PlcTertiary Minerals has started its biggest-ever drilling programme in Zambia, aiming to define a maiden resource and test for extensions.
Eco Buildings Group plcBegun building AI-enabled manufacturing platform in Albania to boost efficiency and support global expansion.
Frontier IP Group PlcPortfolio company 2D Photonics received €211 million funding boost, a major milestone.
Bitcoin